BF647标记的组织蛋白酶A抗体

2026-01-04~2026-02-28,ZB1888
货号:bs-6040R-BF647
产品详情
相关产品
相关文献
常见问题

概述

产品编号
bs-6040R-BF647
英文名称
Protective protein/Cathepsin A Rabbit pAb, BF647 conjugated
中文名称
BF647标记的组织蛋白酶A抗体
英文别名
Cathepsin A; CTSA; BETA GALACTOSIDASE PROTECTIVE PROTEIN; Carboxypeptidase C; Glactosialidosis; GLB2; Goldberg Syndrome; GSL; Lysosomal protective protein; NEURAMINIDASE BETA GALACTOSIDASE EXPRESSION; NGBE; NGBE; PPCA; PPGB; Protective protein for beta galactosidase; PPGB_HUMAN.
标记
BF647
Excitation spectrum: 647nm
Emission spectrum: 666nm
抗体来源
Rabbit
免疫原
KLH conjugated synthetic peptide derived from human Protective protein: 401-480/480
亚型
IgG
纯化方法
affinity purified by Protein A
克隆类型
Polyclonal
浓度
1mg/ml
储存液
0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
SWISS
Gene ID
保存条件
Shipped at 4℃. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
背景资料
Lysosomal protective protein/cathepsin A (PPCA) is a lysosomal serine carboxypeptidase that forms an intralysosomal enzyme complex with ?galactosidase and neuraminidase (NEU1). PPCA is synthesized as a 54 kDa precursor/zymogen, and proteolytically cleaved in the lysosome into a catalytically active 32 and 20 kDa two chain enzyme. The enzyme has cathepsin A activity at acidic pH but maintains also a deamidase/esterase activity at neutral pH. Furthermore, the human enzyme, purified from platelets and lymphocytes, has been shown to function on the inactivation of selected neuropeptides, like substance P, oxytocin, and endothelin I. The autosomal recessive genetic deficiency of PPCA causes galactosialidosis, a neurodegenerative lysosomal storage disorder, resulting in the secondary deficiencies of ?galactosidase and NEU1.

产品应用

应用已检合格种属预测种属推荐稀释比例
IFHuman, Mouse, Rat, Pig, Cow, Dog, Horse1:100-500

交叉反应

交叉反应: Human, Mouse, Rat (predicted: Pig, Cow, Dog, Horse)

相关产品

暂无相关产品

靶标

基因名
CTSA
蛋白名
Lysosomal protective protein
亚基
Heterodimer of a 32 kDa chain and a 20 kDa chain; disulfide-linked.
亚细胞定位
Lysosome.
疾病
Defects in CTSA are the cause of galactosialidosis (GSL) [MIM:256540]. A lysosomal storage disease associated with a combined deficiency of beta-galactosidase and neuraminidase, secondary to a defect in cathepsin A. All patients have clinical manifestations typical of a lysosomal disorder, such as coarse facies, cherry red spots, vertebral changes, foam cells in the bone marrow, and vacuolated lymphocytes. Three phenotypic subtypes are recognized. The early infantile form is associated with fetal hydrops, edema, ascites, visceromegaly, skeletal dysplasia, and early death. The late infantile type is characterized by hepatosplenomegaly, growth retardation, cardiac involvement, and a normal or mildly affected mental state. The juvenile/adult form is characterized by myoclonus, ataxia, angiokeratoma, mental retardation, neurologic deterioration, absence of visceromegaly, and long survival.
相似性
Belongs to the peptidase S10 family.
功能
Protective protein appears to be essential for both the activity of beta-galactosidase and neuraminidase, it associates with these enzymes and exerts a protective function necessary for their stability and activity. This protein is also a carboxypeptidase and can deamidate tachykinins.

标记抗体

暂无标记数据

同靶标产品

暂无同靶标产品

相关文献

提示: 发表研究结果有使用 bs-6040R-BF647 时请让我们知道,以便我们可以引用参考文章。作为回馈,资料提供者将获得我们送上的小礼品。
具体参考文献:bs-6040R-BF647 被引用于1文献中

暂无相关文献

常见问题

暂无常见问题